Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in DRTS — Alpha Tau Medical Ltd.

CIK 1000275 TORONTO, A6
Back to DRTS Full portfolio

Position in DRTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,128
+$13,058 QoQ
Shares Held
1,600
+60.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 74 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DRTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. DRTS ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in DRTS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,128 1,600
2026-03-31 $7,070 1,000
2024-09-30 $3,570 1,500
2024-06-30 $3,795 1,500
2024-03-31 $4,425 1,500
2023-12-31 $4,515 1,500
2023-09-30 $5,685 1,500
2023-06-30 $6,555 1,500
2023-03-31 $4,305 1,500
2022-12-31 $3,180 1,000
2022-09-30 $5,840 1,000
2022-06-30 $11,649 1,293